Humana (HUM) Other Accumulated Expenses (2009 - 2026)

Humana (HUM) has 18 years of Other Accumulated Expenses data on file, last reported at $12.7 billion in Q1 2026.

• On a quarterly basis, Other Accumulated Expenses rose 10.83% year-over-year to $12.7 billion in Q1 2026; TTM through Mar 2026 was $12.7 billion, a 10.83% increase from a year earlier, with the FY2025 full-year figure at $10.0 billion, down 4.53% from the prior year.
• Other Accumulated Expenses for Q1 2026 stood at $12.7 billion, up from $10.0 billion in the prior quarter.
• Over the last five years, Other Accumulated Expenses for HUM reached as high as $12.7 billion in Q1 2026 and fell as low as $9.2 billion in Q3 2022.
• Historically, Other Accumulated Expenses has averaged $10.5 billion across 5 years, with a median of $10.2 billion in 2023.
• Across the five-year window, Other Accumulated Expenses grew 17.08% in 2024 and fell 9.32% in 2025, its largest moves.
• Year by year, Other Accumulated Expenses stood at $9.3 billion in 2022, then grew by 10.55% to $10.2 billion in 2023, then increased by 1.94% to $10.4 billion in 2024, then dropped by 4.53% to $10.0 billion in 2025, then climbed by 27.33% to $12.7 billion in 2026.
• Per Business Quant data, the three most recent Other Accumulated Expenses figures were $12.7 billion in Q1 2026, $10.0 billion in Q4 2025, and $10.1 billion in Q3 2025.